Jaypee Brothers Medical Publishers was established in the year 1969. For a medical professional, the partnership with Jaypee begins at the undergraduate level. Jaypee remains every doctor’s trusted education resource for all his/her professional life. Be it undergraduate, postgraduate, ward round handbooks or be it the professional and reference books for practitioners. Jaypee as South Asia’s largest and fastest growing medical publisher and has become a popular and trusted brand among the medical fraternity. We work closely with health care professionals as well as health care information providers and pioneer in medical contents. It works like a Bumblebee, collecting the pollen of knowledge from the KOLs (Key Opinion Leaders) of the field and spreading information in the garden of health sciences for every seeking learner.
Headquartered in New Delhi (India), Jaypee is a global company and its cerebral resource collection centres are located in UK, USA, and Panama. As a well reputed publisher in the world, Jaypee has been publishing the works of eminent KOLs and academicians from every nook and corner of the world. Jaypee makes its presence in each and every important medical conference of the world to connect with every possible KOL of the medical world in every important specialty to collect and publish the latest, authoritative and dependable information, knowledge and techniques of and for the medical world.
Jaypee is actively involved in the translations of titles in different languages like Spanish, Portuguese, Arabic, Chinese, Korean, etc.
The company is the publisher of Federation of Obstetrics and Gynecological Societies of India (FOGSI), Indian Academy of Pediatrics (IAP) and the Association of Physicians in India (API). With more than 3,500 titles (health science books, journals and procedures’ video) in its list and 350 new products added each year in different streams: Medical, Dental, Nursing, Allied and Medical Science, Veterinary Sciences. Jaypee is one of the fastest growing publishers in the world of Health Sciences Education and information.
Jaypee has already achieved the distinction of being one of the best publishers in the world in the field of Ophthalmology. The coveted TOP position in the specialty is not far away.
With 20 offices in the Indian subcontinent, it is the undisputed leader of the region. Apart from distributing its own books Jaypee is a distributor as well in the Indian subcontinent for McGraw Hill, Arnold, FA Davis, Elsevier, LWW, Springer and Thieme’s products. Jaypee has a great network of more than 1100 booksellers in different regions to reach all its existing and prospective clients.
Jaypee products are being distributed globally by renowned distributors in the USA, Central and South America, UK, Canada, Europe, Africa, Middle East, South East Asia, North Asia and in the Australia/Pacific Region.
JP Medical Ltd. based in London (UK) is an exclusive distributor of Jaypee’s books, journals, videos and online services in Europe and North America. The company has an extensive network in UK and USA to reach out to the KOL’s of the region. As this is a full services publishing subsidiary, it extensively draws the content from the authors, writers and contributors of the region. Established in 2010 JP Medical is the exclusive distributor of Jaypee Brothers books, journals and online services in Europe, the Middle East and North America and also publishes new titles from authors in these regions. JP Medical is committed to publishing information with clarity of text, design and purpose relevant to the busy medical professional and student at realistic prices.
Jaypee-Highlights Medical Publishers, Inc. is based in Panama (Central America), offering professional and reference books, textbooks, journals, videos, e-books in Spanish, English, Italian and Portuguese languages, covering over 44 different medical specialities. Jaypee-Highlights’s staff works closely with international renowned authors, combining creativity and technology to publish unique, innovative and outstanding quality products to educate and inform students, researchers, academicians, specialists and other health professionals on the latest developments and most recent advances and techniques in all the areas of medicine. The company also distributes Jaypee’s English products in the region. The company already has a formidable list of titles in the Medical, Dental and Nursing streams. The company’s roots are deeply embedded in the field of Ophthalmology.
JP Medical Publishers and Jaypee-Highlights is managed and run by a strong team of experienced publishing professionals in the field of Health Sciences.
• Jaypee Journals: Print and e-Journals
• Jaypee Digital (e-books & e-Journals): Digital Medical Books and Journals
• Jaypee Pharma Customized Imprints (P) Ltd.
• AJR Medi Solutions etc.
• Corporate Social Responsibility (“CSR”) at Jaypee Brothers Medical Publishers Private Limited (“Company”) portrays the deep symbiotic relationship that the Company enjoys with the communities it is engaged with. Along with sustainable economic performance, environmental and social stewardship is also a key factor for holistic business growth. As a responsible corporate citizen, we try to contribute for social and economic development on regular basis. We believe that to succeed, an organization must maintain highest standards of corporate behaviour towards it employees, consumers and societies in which it operates. We are of opinion that CSR underlines the objective of bringing about a difference and adding value in our stakeholder’s lives.
• This CSR Policy shall operate as the Corporate Social Responsibility Policy of the Company for the purposes of Section 135 of the Companies Act, 2013 and the rules made thereunder including the Companies (Corporate Social Responsibility Policy) Rules 2014(“CSR Rules”) as amended from time to time.
• Jaypee Brothers Medical Publishers Private Limited CSR Policy has been formulated in consonance with Section 135 of the Companies Act, 2013 read with the CSR Rules notified by the Ministry of Corporate Affairs, Government of India.
• This Policy shall apply to all CSR projects / programmes undertaken by the Company in India as per the Companies Act, 2013.
• Through sustainable measures, actively contribute to the social, economic and environmental development of the community in which the Company operates ensuring participation from the community and thereby create value for the nation.
• The CSR Committee will annually recommend the CSR programmes and projects to the Board for its approval. The Board of Directors of the Company through its CSR Committee will plan and monitor the expenditure of CSR activities.
“Act” means the Companies Act, 2013, as amended from time to time.
“Board” means the Board of Directors of the Company.
“Company” means ‘Jaypee Brothers Medical Publishers Private Limited’.
“CSR” means Corporate Social Responsibility.
“CSR Committee” means Corporate Social Responsibility Committee of the Company constituted by the Board.
“CSR Rules” means Companies (Corporate Social Responsibility Policy) Rules 2014 and amendments thereon.
“CSR Policy” means this Policy.
“CSR Expenditure” shall include all expenditure including contribution to corpus, for projects or programs relating to CSR activities approved by the Board on the recommendation of its CSR Committee.
“Net profit” shall have the meaning ascribed to it in the Act.
“NGO” means non-governmental organisation.
• The Company proposes to adopt one or more of the following CSR activities as prescribed by applicable laws, including Schedule VII of the Companies Act, 2013, as amended from time to time:
(i) eradicating hunger, poverty and malnutrition, promoting health care (including preventive health care) and sanitation including contribution to the Swach Bharat Kosh set-up by the Central Government for the promotion of sanitation and making available safe drinking water;
(ii) Promoting education, including special education and employment enhancing vocation skills especially among children, women, elderly, and the differently abled and livelihood enhancement projects;
(iii) promoting gender equality empowering women, setting up homes and hostels for women and orphans; setting up old age homes, day care centres and such other facilities for senior citizens and measures for reducing inequalities faced by socially and economically backward groups;
(iv) ensuring environmental sustainability, ecological balance, protection of flora and fauna, animal welfare, agroforestry, conservation of natural resources and maintaining quality of soil, air and water including contribution to Clean Ganga Fund set-up by the Central Government for rejuvenation of river Ganga;
(v) protection of national heritage, art and culture including restoration of buildings and sites of historical importance and works of art; setting up public libraries; promotion and development of traditional arts and handicrafts;
(vi) measures for the benefit of armed forces veterans, war widows and their dependents;
(vii) training to promote rural sports, nationally recognised sports, paralympic sports and Olympic sports;
(viii) contribution to the Prime Minister's National Relief Fund or any other fund set up by the Central Government for socio-economic development and relief and welfare of the Scheduled Castes, the Scheduled Tribes, other backward classes, minorities and women;
(ix) contributions or funds provided to technology incubators located within academic institutions which are approved by the Central Government;
(x) rural development projects.
• The CSR activities shall be undertaken within the territory of the Republic of India
• The Company’s CSR projects and programmes will be undertaken by the Company by itself or with joint and collaborative efforts of other companies.
• The CSR projects and programmes may also be implemented through registered public charitable trusts, not-for-profit companies set up under Section 25 of the Companies Act, 1956 corresponding to Section 8 of the Companies Act, 2013) through recognized and reputed NGOs and similar entities.
• The CSR policy and programs shall be implemented, managed and supervised by the CSR committee appointed by the Board
• The CSR Committee shall comprise at least of such number of directors as is mandatorily required by applicable laws.
• The Committee shall inter alia:
- Formulate and update the CSR Policy which will be approved by the Board;
- Decide the CSR activities to be taken up by the Company in accordance with this Policy;
- Decide the amount to be allocated for each project or activity;
- Oversee and monitor the progress of the initiatives rolled out under this Policy; and
- Submit a report, to the Board on all CSR activities undertaken during the financial year
- The Committee shall meet at least once in a financial year.
The responsibilities of the CSR Committee include:
• Formulating and recommending to the Board of Director the CSR Policy and indicating activities to be undertak
• Recommending the amount of expenditure for the CSR activities, and
• Monitoring CSR activities from time to time
• Such other functions as the Board of Directors may deem fit
• After taking into account the recommendations made by the CSR Committee, approve the CSR Policy for the Company.
• Ensure that the CSR activities included in this Corporate Social Responsibility Policy are undertaken by the Company.
• The Board of the Company may decide to undertake its CSR activities approved by the CSR Committee, through a registered trust or a registered society or a Company established under section 8 of the Act by the company, either singly or along with its holding or subsidiary or associate company, or along with any other company or holding or subsidiary or associate company of such other company, or otherwise provided that –
• If such trust, society or company is not established by the company, either singly or along with its holding or subsidiary or associate company, or along with any other
• company or holding or subsidiary or associate company of such other company, it shall have an established track record of three years in undertaking similar programs or projects/activities;
• Ensure that in each financial year the Company spends at least 2% of the average net profits of the company made during the three immediate preceding financial years, calculated in accordance with Section 198 of the Act, in pursuance of its CSR policy. Further, while spending the amount earmarked for CSR activities, preference should be given to local areas and areas around the Company where it operates,
• As per Section 135 of the Act, specify the reasons for under spending the CSR amount in the Board’s Report.
The CSR policy recommended by the CSR Committee and approved by the Board shall be displayed on the Company’s website and shall be disclosed in the Board’s report as well.
The Board Report of a Company shall include an Annual Report on CSR containing particulars specified in Annexure to the CSR Rules as per the prescribed format.
• Every year, the Company shall with the approval of its Board make a budgetary allocation for CSR activities/ projects for the year. The budgetary allocation will be based on the profitability of the Company and the requirements of applicable laws.
• The Company expects to spend the budgeted amount allocated for CSR activities/ projects planned for each financial year, within that year. If for any reason, the budget of a year remains unutilised, the same would not lapse and would be carried forward to the next year for expenditure on CSR activities, which were planned for implementation in the previous year, but could not be completed due to some reason.
• The CSR Committee and the Board of Directors will disclose the reasons for not being able to spend the entire budgeted amount on the CSR activities as planned for that year.
• The amount allocated for emergency needs but not utilised in the year of its allocation may be carried forward to the next year for utilization for CSR activities.
• Any surplus arising out of the CSR activities, projects or programs shall not form part of the business profits of the Company.
• The CSR Activities would be chosen for implementation by the Company in compliance with the provisions of Section 135 read together with Schedule VII of the Companies Act, 2013.
• The Company recognises that monitoring is critical for assessment of the progress as regards timelines, budgetary expenditure and achievement of targets. Monitoring maybe done periodically with the help of identified key performance indicators, the periodicity being determined primarily by the nature of key performance indicators.
• Monitoring will be done in project mode with continuous feedback mechanism, and recourse always available for mid-course correction in implementation, whenever required.
• The performance of the Company’s CSR activities would be monitored on the basis of their achievement of annual targets and the utilization of their annual budgets for the activities planned and the targets set for each year.
• Implementation and monitoring of the CSR activities will be overseen by the CSR Committee. The monitoring and evaluation may be assigned by the CSR Committee to an independent external agency for the sake of objectivity and transparency.
• If the projects are being implemented by external agencies, the Company may in consultation with CSR Committee designate special executives for this purpose.
• In case of any doubt with regard to any provision of this CSR Policy and also in respect of matters not covered herein, a reference should be made to the CSR Committee. In all such matters, the interpretation and decision of the CSR Committee shall be final.
• All provisions of the CSR Policy would be subject to revision/amendment in accordance with the applicable laws.
• The Company reserves the right to modify, cancel, add, or amend this CSR Policy.
• Minimum 2 (Two) members shall constitute a quorum for the committee meeting.
• Proceedings of all meetings must be signed by the Chairman of the Committee and tabled at the subsequent Board and Committee meeting.
The CSR Committee shall review the CSR Policy from time to time based on the changing needs and make suitable modifications as may be necessary with the approval of the Board.
In case of any amendment(s), clarification(s), circular(s) etc. issued by the relevant authorities, not being consistent with the provisions laid down under this Policy, then such amendment(s), clarification(s), circular(s) etc. shall prevail upon the provisions hereunder and this Policy shall stand amended accordingly from the effective date as laid down under such amendment(s), clarification(s), circular(s) etc.